Yazıcı, O. Et Al. 2021. Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8 , 1229-1235.

Yazıcı, O., Doğan, M., Özal, G., Aktaş, S. H., Demirkazık, A., Utkan, G., ... Senler, F. C.(2021). Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, 1229-1235.

Yazıcı, Ozan Et Al. "Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer," COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, 1229-1235, 2021

Yazıcı, Ozan Et Al. "Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer." COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, pp.1229-1235, 2021

Yazıcı, O. Et Al. (2021) . "Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer." COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , vol.24, no.8, pp.1229-1235.

@article{article, author={Ozan Yazıcı Et Al. }, title={Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer}, journal={COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING}, year=2021, pages={1229-1235} }